Clinical significance of eosinophilia in HIV-infected individuals

D. J. Skiest, Philip Keiser

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

PURPOSE: To assess the clinical significance of peripheral eosinophilia in HIV-infected individuals. METHODS: In a retrospective case-control study we compared 42 HIV-infected patients (cases) with peripheral eosinophilia (absolute eosinophil count > 500 cells/mm3) with 84 HIV-infected controls without eosinophilia. Cases were matched to controls by date, and by CD4 cell count. Data on clinical parameters possibly associated with eosinophilia were collected and compared among cases and control. RESULTS: Eosinophilia was seen in patients with late-stage HIV disease (median CD4 cell count of 26 cells/mm3). Cases were more likely to be black (52% versus 18%, P = 0.0001), have pruritus (50% versus 20%, P = 0.002), and have a physician-documented rash (76% versus 52%, P = 0.02). Specific cutaneous diagnoses that were more prevalent in cases versus controls were eosinophilic folliculitis (24% versus 1%, P = 0.0001), atopic dermatitis (14% versus 1%, P = 0.01), and prurigo nodularis (7% versus 0, P = 0.07). Other parameters commonly associated with eosinophilia such as allergic reactions, parasitic infection, malignancy, and adrenal insufficiency were not found at higher incidence in cases. CONCLUSIONS: Eosinophilia in AIDS patients is associated with cutaneous disease, but not with other conditions commonly associated with eosinophilia including parasitic infections, allergic reactions, or malignancy. Extensive work up for asymptomatic eosinophilia in patients with AIDS and cutaneous disease is not warranted.

Original languageEnglish (US)
Pages (from-to)449-453
Number of pages5
JournalAmerican Journal of Medicine
Volume102
Issue number5
DOIs
StatePublished - 1997
Externally publishedYes

Fingerprint

Eosinophilia
HIV
Parasitic Diseases
CD4 Lymphocyte Count
Skin Diseases
Hypersensitivity
Acquired Immunodeficiency Syndrome
Prurigo
Folliculitis
Adrenal Insufficiency
Atopic Dermatitis
Pruritus
Exanthema
Eosinophils
Case-Control Studies
Neoplasms
Physicians
Skin
Incidence

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Clinical significance of eosinophilia in HIV-infected individuals. / Skiest, D. J.; Keiser, Philip.

In: American Journal of Medicine, Vol. 102, No. 5, 1997, p. 449-453.

Research output: Contribution to journalArticle

@article{b0ec726fc0e94431ac284d2ffb5dd594,
title = "Clinical significance of eosinophilia in HIV-infected individuals",
abstract = "PURPOSE: To assess the clinical significance of peripheral eosinophilia in HIV-infected individuals. METHODS: In a retrospective case-control study we compared 42 HIV-infected patients (cases) with peripheral eosinophilia (absolute eosinophil count > 500 cells/mm3) with 84 HIV-infected controls without eosinophilia. Cases were matched to controls by date, and by CD4 cell count. Data on clinical parameters possibly associated with eosinophilia were collected and compared among cases and control. RESULTS: Eosinophilia was seen in patients with late-stage HIV disease (median CD4 cell count of 26 cells/mm3). Cases were more likely to be black (52{\%} versus 18{\%}, P = 0.0001), have pruritus (50{\%} versus 20{\%}, P = 0.002), and have a physician-documented rash (76{\%} versus 52{\%}, P = 0.02). Specific cutaneous diagnoses that were more prevalent in cases versus controls were eosinophilic folliculitis (24{\%} versus 1{\%}, P = 0.0001), atopic dermatitis (14{\%} versus 1{\%}, P = 0.01), and prurigo nodularis (7{\%} versus 0, P = 0.07). Other parameters commonly associated with eosinophilia such as allergic reactions, parasitic infection, malignancy, and adrenal insufficiency were not found at higher incidence in cases. CONCLUSIONS: Eosinophilia in AIDS patients is associated with cutaneous disease, but not with other conditions commonly associated with eosinophilia including parasitic infections, allergic reactions, or malignancy. Extensive work up for asymptomatic eosinophilia in patients with AIDS and cutaneous disease is not warranted.",
author = "Skiest, {D. J.} and Philip Keiser",
year = "1997",
doi = "10.1016/S0002-9343(97)00048-X",
language = "English (US)",
volume = "102",
pages = "449--453",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Clinical significance of eosinophilia in HIV-infected individuals

AU - Skiest, D. J.

AU - Keiser, Philip

PY - 1997

Y1 - 1997

N2 - PURPOSE: To assess the clinical significance of peripheral eosinophilia in HIV-infected individuals. METHODS: In a retrospective case-control study we compared 42 HIV-infected patients (cases) with peripheral eosinophilia (absolute eosinophil count > 500 cells/mm3) with 84 HIV-infected controls without eosinophilia. Cases were matched to controls by date, and by CD4 cell count. Data on clinical parameters possibly associated with eosinophilia were collected and compared among cases and control. RESULTS: Eosinophilia was seen in patients with late-stage HIV disease (median CD4 cell count of 26 cells/mm3). Cases were more likely to be black (52% versus 18%, P = 0.0001), have pruritus (50% versus 20%, P = 0.002), and have a physician-documented rash (76% versus 52%, P = 0.02). Specific cutaneous diagnoses that were more prevalent in cases versus controls were eosinophilic folliculitis (24% versus 1%, P = 0.0001), atopic dermatitis (14% versus 1%, P = 0.01), and prurigo nodularis (7% versus 0, P = 0.07). Other parameters commonly associated with eosinophilia such as allergic reactions, parasitic infection, malignancy, and adrenal insufficiency were not found at higher incidence in cases. CONCLUSIONS: Eosinophilia in AIDS patients is associated with cutaneous disease, but not with other conditions commonly associated with eosinophilia including parasitic infections, allergic reactions, or malignancy. Extensive work up for asymptomatic eosinophilia in patients with AIDS and cutaneous disease is not warranted.

AB - PURPOSE: To assess the clinical significance of peripheral eosinophilia in HIV-infected individuals. METHODS: In a retrospective case-control study we compared 42 HIV-infected patients (cases) with peripheral eosinophilia (absolute eosinophil count > 500 cells/mm3) with 84 HIV-infected controls without eosinophilia. Cases were matched to controls by date, and by CD4 cell count. Data on clinical parameters possibly associated with eosinophilia were collected and compared among cases and control. RESULTS: Eosinophilia was seen in patients with late-stage HIV disease (median CD4 cell count of 26 cells/mm3). Cases were more likely to be black (52% versus 18%, P = 0.0001), have pruritus (50% versus 20%, P = 0.002), and have a physician-documented rash (76% versus 52%, P = 0.02). Specific cutaneous diagnoses that were more prevalent in cases versus controls were eosinophilic folliculitis (24% versus 1%, P = 0.0001), atopic dermatitis (14% versus 1%, P = 0.01), and prurigo nodularis (7% versus 0, P = 0.07). Other parameters commonly associated with eosinophilia such as allergic reactions, parasitic infection, malignancy, and adrenal insufficiency were not found at higher incidence in cases. CONCLUSIONS: Eosinophilia in AIDS patients is associated with cutaneous disease, but not with other conditions commonly associated with eosinophilia including parasitic infections, allergic reactions, or malignancy. Extensive work up for asymptomatic eosinophilia in patients with AIDS and cutaneous disease is not warranted.

UR - http://www.scopus.com/inward/record.url?scp=0030908753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030908753&partnerID=8YFLogxK

U2 - 10.1016/S0002-9343(97)00048-X

DO - 10.1016/S0002-9343(97)00048-X

M3 - Article

VL - 102

SP - 449

EP - 453

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 5

ER -